Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Human serum albumin is a sterile protein solution derived from pooled human venous plasma. It is the primary protein responsible for maintaining the colloid osmotic (oncotic) pressure of blood, which prevents fluid from leaking out of blood vessels into tissues. Additionally, it functions as a transport protein for hormones, fatty acids, and drugs. In the context of the study by The First Hospital of Jilin University, it is administered intravenously to patients undergoing radical gastric cancer surgery to manage postoperative hypoalbuminemia. The study specifically investigates the clinical outcomes of different albumin infusion thresholds (25 g/L vs 30 g/L) to optimize perioperative care and reduce complications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on human serum albumin.